Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Published:2017-01 Issue:1 Volume:18 Page:100-103
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Yoneshima Yasuto,Morita Satoshi,Ando Masahiko,Miura Satoru,Yoshioka Hiroshige,Abe Tetsuya,Kato Terufumi,Kondo Masashi,Hosomi Yukio,Hotta Katsuyuki,Yamamoto Nobuyuki,Kishimoto Junji,Nakanishi Yoichi,Okamoto Isamu

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference12 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Impact of EGFR inhibitor in non–small cell lung cancer on progression-free and overall survival: a meta-analysis;Lee;J Natl Cancer Inst,2013

3. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N Engl J Med,2015

5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non–small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of induction therapy including nab-paclitaxel followed by surgical resection for the patients with locally advanced non-small-cell lung cancer;Journal of Cardiothoracic Surgery;2024-07-05

2. Hemorrhagic cystitis in gastric cancer after nanoparticle albumin-bound paclitaxel: A case report;World Journal of Gastrointestinal Oncology;2024-03-15

3. Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment;Clinical Lung Cancer;2022-11

4. Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Annals of Pharmacotherapy;2021-12-28

5. Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402;Thoracic Cancer;2021-09-14